Capital Midwest Fund — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
SeaStar Medical develops the Selective Cytopheretic Device (SCD), a therapy that targets highly activated neutrophils and monocytes to neutralize the hyperinflammatory immune response in critically ill ICU patients facing conditions such as infection, trauma, or surgery.
BiotechHealthtechMedical DevicesDenver, US
H David Humes(Director)Eric Schlorff(Executive Officer, Director)inPeter DeComo(Director)Mark Morsfield(Executive Officer)R James Danehy(Executive Officer, Director)
BoardAlvin Vitangcol(Director)
Co-investorsAphelion CapitalEarly Stage Partners, LPWMU Biosciences Research & Commercialization Center
AdAdapted is a commerce media platform for CPG brands and agencies that targets high-intent shoppers and converts digital discovery into retail purchases through its patented one-click "Add-It" technology, including one-click carting, recipes, and retailer integrations.
AdTechConsumerMarketing TechRetail TechAnn Arbor, US
Molly McFarland(Executive Officer)inMichael Pedersen(Executive Officer, Director)
BoardRobert Cell(Director, Promoter)Terese Hunwick(Director)
Co-investorsID VenturesInvest MichiganTappan Hill VenturesWakestream Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.